The role of Epstein-Barr virus in lymphoid malignancies (Q41553353)

3 October 2017

title

The role of Epstein-Barr virus in lymphoid malignancies (English)

1 reference

3 October 2017

1 reference

I. J. Su

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9246539

10 November 2024

J. Y. Chen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9246539

10 November 2024

publication date

1 May 1997

1 reference

3 October 2017

May 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9246539

10 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9246539

http://ntur.lib.ntu.edu.tw/news/agent_contract.pdf

10 November 2024

work available at URL

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9246539

https://api.elsevier.com/content/article/PII:S1040842897000085?httpAccept=text/xml

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00008-5

https://api.elsevier.com/content/article/PII:S1040842897000085?httpAccept=text/plain

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00008-5

Critical Reviews in Oncology Hematology

10 November 2024

published in

1 reference

3 October 2017

volume

26

1 reference

3 October 2017

issue

1

1 reference

3 October 2017

page(s)

25-41

1 reference

publication type of scholarly work

3 October 2017

review article

1 reference

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Lymphoproliferative diseases in immunocompromised hosts: the role of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Burkitt's lymphoma in a homosexual

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Outbreak of Burkitt's-like lymphoma in homosexual men.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Epstein-Barr viral DNA in Hodgkin's disease: amplification and detection using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Immunohistochemical demonstration of the Epstein-Barr virus-encoded latent membrane protein in paraffin sections of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

High frequency of Epstein-Barr virus in Chinese peripheral T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21).

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Infection of human thymocytes by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Epstein-Barr virus superinduces a new human b cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Early events in Epstein-Barr virus infection provide a model for B cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Epstein Barr virus (EBV) encoded small RNAs: targets for detection by in situ hybridisation with oligonucleotide probes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Induction of CD44 expression by the Epstein-Barr virus latent membrane protein LMP1 is associated with lymphoma dissemination

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Epstein-Barr virus strategy in normal and neoplastic B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Detection of an Epstein-Barr-virus variant in T-cell-lymphoma tissues identical to the distinct strain observed in nasopharyngeal carcinoma in the Taiwanese population

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Reciprocal antagonism of steroid hormones and BZLF1 in switch between Epstein-Barr virus latent and productive cycle gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Observations on childhood infections with the Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

X-linked recessive progressive combined variable immunodeficiency (Duncan's disease)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Fulminant childhood hemophagocytic syndrome mimicking histiocytic medullary reticulosis. An atypical form of Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Deregulated c-myc expression in Epstein-Barr-virus-immortalized B-cells induces altered growth properties and surface phenotype but not tumorigenicity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Evolution of tumours and the impact of molecular oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Cyclosporin A immunosuppression, Epstein-Barr antibody, and lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Alterations of the p53 gene in Epstein-Barr virus-associated immunodeficiency-related lymphomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders. Implications for lymphomagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Small noncleaved B cell Burkitt-like lymphoma with chromosome t(8;14) translocation and Epstein-Barr virus nuclear-associated antigen in a homosexual man with acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Primary cerebral lymphoma: a study of 47 cases probed for Epstein-Barr virus genome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Demonstration of Epstein-Barr virus in primary brain lymphoma by in situ DNA hybridisation in paraffin wax embedded tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Epstein-Barr virus receptor expression on human CD8+ (cytotoxic/suppressor) T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Interaction between Epstein-Barr virus and a T cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Presence of Epstein-Barr virus DNA in nasal lymphomas of B and 'T' cell type

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

In situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: a clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

CD56 (NKH1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Experience of radiotherapy in lethal midline granuloma with special emphasis on centrofacial T-cell lymphoma: a retrospective analysis covering a 34-year period

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Angiocentric T-cell lymphoma of the intestine: a distinct etiology of ischemic bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Cutaneous angiocentric T-cell lymphoma associated with Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Epstein-Barr virus-associated peripheral T-cell lymphoma of activated CD8 phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Detection of Epstein-Barr virus DNA by polymerase chain reaction in lymph node biopsies from patients with angioimmunoblastic lymphadenopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

High incidence of EBV genome in CD30-positive non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Epstein-Barr virus-containing T-cell lymphoma presents with hemophagocytic syndrome mimicking malignant histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Clinicopathological spectrum of haemophagocytic syndrome in Epstein-Barr virus-associated peripheral T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Prognosis of Children with Virus-Associated Hemophagocytic Syndrome and Malignant Histiocytosis: Correlation with Levels of Serum Interleukin-1 and Tumor Necrosis Factor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumor in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Epstein-Barr virus in tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Epstein-Barr virus infections and Hodgkin's disease: a study of fixed tissues using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Epstein-Barr virus (EBV) and Hodgkin's disease in children: incidence of EBV latent membrane protein in malignant cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Prognosis of Hodgkin's disease is not influenced by Epstein-Barr virus latent membrane protein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

EBV strain variation: geographical distribution and relation to disease state

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Distribution and localization of Epstein-Barr virus subtypes A and B in AIDS-related lymphomas and lymphatic tissue of HIV-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Epstein-Barr virus type B in patient with T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Epstein-Barr virus types 1 and 2 have nearly identical LMP-1 transforming genes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Cytogenetic characterization of Epstein-Barr virus-associated T-cell malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Expression of P-glycoprotein and glutathione-S-transferase in recurrent lymphomas: the possible role of Epstein-Barr virus, immunophenotypes, and other predisposing factors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900008-5

7 January 2021

Demonstration of a Herpes Group Virus in Cultures of Peripheral Leukocytes from Patients with Infectious Mononucleosis

3

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00008-5

The Epstein-Barr virus (EBV) in the pathogenesis of posttransplant lymphoma

10 November 2024

83

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00008-5

Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus

10 November 2024

91

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00008-5

10 November 2024

Identifiers

1 reference

3 October 2017

1 reference